COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 669: Articles 6681-6690  | Next

Evaluation of the Abbott PanbioTM COVID-19 antigen detection rapid diagnostic test among healthcare workers in elderly care
Eikelenboom-Boskamp, A., den Ouden, M., de Groot, T., Stobernack, T., Wertheim, H., Voss, A.
10.1101/2022.10.04.22280700 — Posted: 2022-10-06
Vaccines alone cannot slow the evolution of SARS-CoV-2
Van Egeren, D., Stoddard, M., White, L., Hochberg, N. S., Rogers, M. S., Zetter, B., Joseph-McCarthy, D., Chakravarty, A.
10.1101/2022.10.04.22280696 — Posted: 2022-10-06
Age-dependent impairment in antibody responses elicited by a homologous CoronaVac booster dose
Filardi, B. A., Monteiro, V. S., Schwartzmann, P. V., Martins, V. d. P., Rosa Zucca, L. E., Baiocchi, G. C., Hahn, A. M., Chen, N., Pham, K., Perez-Then, E., Miric, M., Brache, V., Cochon, L., Larocca, R., Yale SARS-CoV-2 Genomic Surveillance Initiative,, , Mendez, R. D. R., Silveira, D. B., Pinto, A. R., Croda, J., Yildirim, I., Omer, S. B., Ko, A., Vermund, S., Grubaugh, N. D., Iwasaki, A., Lucas, C.
10.1101/2022.10.04.22280704 — Posted: 2022-10-06
Potential use of Immunodaat (Botanical extract of Elderberry -Sambucus Nigra L.) in the management of Post Covid-19 symptoms- a comparative, multi-centric, randomized, clinical study
Deshpande, S., Mundhe, N., Deshpande, V., Tamoli, S., Mahadik, S., Pawar, V.
10.1101/2022.10.04.22280680 — Posted: 2022-10-06
Key performance indicators of COVID-19 contact tracing in Belgium from September 2020 to December 2021
Kremer, C., Willem, L., Boone, J., Arrazola de Onate, W., Hammami, N., Faes, C., Hens, N.
10.1101/2022.10.04.22280542 — Posted: 2022-10-06
Effectiveness and duration of a second COVID-19 vaccine booster
Jara, A., Cuadrado, C., Undurraga, E. A., Garcia, C., Najera, M., Bertoglia, M. P., Vergara, V., Fernandez, J., Garcia, H., Araos, R.
10.1101/2022.10.03.22280660 — Posted: 2022-10-06
Association between COVID-19 mRNA vaccination and COVID-19 illness and severity during Omicron BA.4 and BA.5 sublineage periods
Link-Gelles, R., Levy, M. E., Natarajan, K., Reese, S. E., Naleway, A. L., Grannis, S. J., Klein, N. P., DeSilva, M. B., Ong, T. C., Gaglani, M., Hartmann, E., Dickerson, M. E., Stenehjem, E., Kharbanda, A. B., Han, J., Spark, T. L., Irving, S. A., Dixon, B. E., Zerbo, O., McEvoy, C. E., Rao, S., Raiyani, C., Sloan-Aagard, C., Patel, P., Dascomb, K., Uhlemann, A.-C., Dunne, M. M., Fadel, W. F., Lewis, N., Barron, M. A., Murthy, K., Nanez, J., Griggs, E. P., Grisel, N., Annavajhala, M., Akinseye, A., Valvi, N. R., Goddard, K., Mamawala, M., Arndorfer, J., Yang, D.-H., Embi, P. J., Fireman, B., Ball, S. W., Tenforde, M. W.
10.1101/2022.10.04.22280459 — Posted: 2022-10-05
Kinetics of naturally induced binding and neutralizing anti-SARS-CoV-2 antibody levels and potencies among Kenyan patients with diverse grades of COVID-19 severity
Kimotho, J., Sein, Y., Sayed, S. M., Shah, R., Mwai, K., Saleh, M., Wanjiku, P., Mwacharo, J., Nyangwange, J., Karanja, H., Kutima, B., Gitonga, J., Mugo, D., Karanu, A., Moranga, L., Oluoch, V., Shah, J., Mutiso, J., Mburu, A. G., Nneka, Z., Betti, P., Mutinda, W. U., Abdi, A. I., Bejon, P., Ochola, I. L., Warimwe, G. M., Nduati, E., Ndungu, F. M.
10.1101/2022.10.05.22280716 — Posted: 2022-10-05
Non-patient related SARS-CoV-2 exposure to colleagues and household members impose the highest infection risk for hospital employees with and without patient contact in a German university hospital: follow-up of the prospective Co-HCW Seroprevalence study
Bahrs, C., Weis, S., Kesselmeier, M., Ankert, J., Hagel, S., Beier, S., Maschmann, J., Stallmach, A., Steiner, A., Bauer, M., Behringer, W., Baier, M., Richert, C., Zepf, F., Walter, M., Scherag, A., Kiehntopf, M., Loeffler, B., Pletz, M.
10.1101/2022.10.05.22280728 — Posted: 2022-10-05
Plasma cytokine levels reveal deficiencies in IL-8 and gamma interferon in Long-COVID
Williams, E. S. C. P., Martins, T. B., Hill, H. R., Coiras, M., Shah, K. S., Planelles, V., Spivak, A. M.
10.1101/2022.10.03.22280661 — Posted: 2022-10-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).